MRE11 and prostate carcinoma: Finally, MRE11 and O-GlcNAc chromatin binding sites overlap with the common prostate cancer small nucleotide polymorphic-loci, and the loss of MRE11 activity is associated with the hyper-mutator phenotype in prostate cancer patient samples.